<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you suffered a loss as a result of Canopy's misconduct, click here.” data-reactid=”19″>If you suffered a loss as a result of Canopy’s misconduct, click here.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Canopy Growth Corp.’s (CGC) Accused of Misleading Shareholders” data-reactid=”20″>Canopy Growth Corp.’s (CGC) Accused of Misleading Shareholders
According to the complaint, in June 2019, Canopy filed its Form 6-K with the SEC, touting fourth quarter 2019 sales of CA$42.5 million and fiscal year 2019 sales of CA$85.3 million from its cannabis oils and softgel capsules, noting that “[o]il and softgel capsules accounted for 40% of gross revenue in the fourth quarter of fiscal ’19.” Then, in August 2019, Canopy released first quarter 2020 cannabis oil and softgel sales of only CA$0.2 million. However Canopy’s CEO assured investors that its “oils and softgel products remain exceptionally popular.” Despite these assurances, in reality, Canopy was experiencing weak demand for its softgel and oil products. As a result, on November 14, 2019, Canopy issued a press release announcing an “astounding” larger-than-expected loss for the quarter, and a CA$32.7 million restructuring charge to modify its retail pricing architecture. On this news, Canopy’s share price fell $2.36, or nearly 14.4%, to close at $15.84 per share.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Canopy Growth Corp. (CGC) Shareholders Have Legal Options” data-reactid=”22″>Canopy Growth Corp. (CGC) Shareholders Have Legal Options
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Contact us to learn more:
Leo Kandinov
(800) 350-6003
[email protected]
Shareholder Information Form” data-reactid=”23″>Contact us to learn more:
Leo Kandinov
(800) 350-6003
[email protected]
Shareholder Information Form
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.” data-reactid=”24″>Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar outcome.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="View source version on businesswire.com: https://www.businesswire.com/news/home/20191218005778/en/” data-reactid=”26″>View source version on businesswire.com: https://www.businesswire.com/news/home/20191218005778/en/
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Contacts” data-reactid=”27″>Contacts
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
[email protected]
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com” data-reactid=”28″>Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
[email protected]
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com
Add Comment